Yujie Feng , Chukwuemeka Clinton Atabansi , Jing Nie , Haijun Liu , Hang Zhou , Huai Zhao , Ruixia Hong , Fang Li , Xichuan Zhou
{"title":"超声图像中前列腺精确分割的多阶段全卷积网络","authors":"Yujie Feng , Chukwuemeka Clinton Atabansi , Jing Nie , Haijun Liu , Hang Zhou , Huai Zhao , Ruixia Hong , Fang Li , Xichuan Zhou","doi":"10.1016/j.bbe.2023.08.002","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Prostate cancer is one of the most commonly diagnosed non-cutaneous malignant tumors and the sixth major cause of cancer-related death generally found in men globally. Automatic segmentation of prostate regions has a wide range of applications in prostate cancer diagnosis and treatment. It is challenging to extract powerful spatial features for precise prostate </span>segmentation methods due to the wide variation in prostate size, shape, and histopathologic heterogeneity among patients. Most of the existing CNN-based architectures often produce unsatisfactory results and inaccurate boundaries in prostate segmentation, which are caused by inadequate discriminative feature maps and the limited amount of spatial information. To address these issues, we propose a novel </span>deep learning<span> technique called Multi-Stage FCN architecture for 2D prostate segmentation that captures more precise spatial information and accurate prostate boundaries. In addition, a new prostate ultrasound image dataset known as CCH-TRUSPS was collected from Chongqing University Cancer Hospital, including prostate ultrasound images of various prostate cancer architectures. We evaluate our method on the CCH-TRUSPS dataset and the publicly available Multi-site T2-weighted MRI dataset using five commonly used metrics for medical image analysis. When compared to other CNN-based methods on the CCH-TRUSPS test set, our Multi-Stage FCN achieves the highest and best binary accuracy of 99.15%, the DSC score of 94.90%, the IoU score of 89.80%, the precision of 94.67%, and the recall of 96.49%. The statistical and visual results demonstrate that our approach outperforms previous CNN-based techniques in all ramifications and can be used for the clinical diagnosis of prostate cancer.</span></p></div>","PeriodicalId":55381,"journal":{"name":"Biocybernetics and Biomedical Engineering","volume":"43 3","pages":"Pages 586-602"},"PeriodicalIF":5.3000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multi-stage fully convolutional network for precise prostate segmentation in ultrasound images\",\"authors\":\"Yujie Feng , Chukwuemeka Clinton Atabansi , Jing Nie , Haijun Liu , Hang Zhou , Huai Zhao , Ruixia Hong , Fang Li , Xichuan Zhou\",\"doi\":\"10.1016/j.bbe.2023.08.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Prostate cancer is one of the most commonly diagnosed non-cutaneous malignant tumors and the sixth major cause of cancer-related death generally found in men globally. Automatic segmentation of prostate regions has a wide range of applications in prostate cancer diagnosis and treatment. It is challenging to extract powerful spatial features for precise prostate </span>segmentation methods due to the wide variation in prostate size, shape, and histopathologic heterogeneity among patients. Most of the existing CNN-based architectures often produce unsatisfactory results and inaccurate boundaries in prostate segmentation, which are caused by inadequate discriminative feature maps and the limited amount of spatial information. To address these issues, we propose a novel </span>deep learning<span> technique called Multi-Stage FCN architecture for 2D prostate segmentation that captures more precise spatial information and accurate prostate boundaries. In addition, a new prostate ultrasound image dataset known as CCH-TRUSPS was collected from Chongqing University Cancer Hospital, including prostate ultrasound images of various prostate cancer architectures. We evaluate our method on the CCH-TRUSPS dataset and the publicly available Multi-site T2-weighted MRI dataset using five commonly used metrics for medical image analysis. When compared to other CNN-based methods on the CCH-TRUSPS test set, our Multi-Stage FCN achieves the highest and best binary accuracy of 99.15%, the DSC score of 94.90%, the IoU score of 89.80%, the precision of 94.67%, and the recall of 96.49%. The statistical and visual results demonstrate that our approach outperforms previous CNN-based techniques in all ramifications and can be used for the clinical diagnosis of prostate cancer.</span></p></div>\",\"PeriodicalId\":55381,\"journal\":{\"name\":\"Biocybernetics and Biomedical Engineering\",\"volume\":\"43 3\",\"pages\":\"Pages 586-602\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biocybernetics and Biomedical Engineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0208521623000402\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biocybernetics and Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0208521623000402","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Multi-stage fully convolutional network for precise prostate segmentation in ultrasound images
Prostate cancer is one of the most commonly diagnosed non-cutaneous malignant tumors and the sixth major cause of cancer-related death generally found in men globally. Automatic segmentation of prostate regions has a wide range of applications in prostate cancer diagnosis and treatment. It is challenging to extract powerful spatial features for precise prostate segmentation methods due to the wide variation in prostate size, shape, and histopathologic heterogeneity among patients. Most of the existing CNN-based architectures often produce unsatisfactory results and inaccurate boundaries in prostate segmentation, which are caused by inadequate discriminative feature maps and the limited amount of spatial information. To address these issues, we propose a novel deep learning technique called Multi-Stage FCN architecture for 2D prostate segmentation that captures more precise spatial information and accurate prostate boundaries. In addition, a new prostate ultrasound image dataset known as CCH-TRUSPS was collected from Chongqing University Cancer Hospital, including prostate ultrasound images of various prostate cancer architectures. We evaluate our method on the CCH-TRUSPS dataset and the publicly available Multi-site T2-weighted MRI dataset using five commonly used metrics for medical image analysis. When compared to other CNN-based methods on the CCH-TRUSPS test set, our Multi-Stage FCN achieves the highest and best binary accuracy of 99.15%, the DSC score of 94.90%, the IoU score of 89.80%, the precision of 94.67%, and the recall of 96.49%. The statistical and visual results demonstrate that our approach outperforms previous CNN-based techniques in all ramifications and can be used for the clinical diagnosis of prostate cancer.
期刊介绍:
Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journal''s mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans.